Reditus Laboratories detects Indian COVID-19 variant in sample from Bloomington-Normal

Photo courtesy of Reditus Laboratories

PEKIN (WEEK) — A Pekin-based laboratory that provides COVID-19 testing results says it has detected the Indian double mutant variant from a sample that was taken in Bloomington-Normal.

The variant was first confirmed in the U.S. on April 3.

The sample that tested for the variant was among Reditus Laboratories’ latest batch. Of the 371 randomly selected, one of the samples tested positive for the variant.

The double mutant variant is of concern because it carries 13 mutations and preliminary evidence indicates that they are potentially more contagious than previous strains of the virus, according to a Reditus news release.

“We’re just alerting the public on what we’ve seen in our latest sequencing runs,” said Reditus CEO Dr. Aaron Rossi.

Reditus sequencing data is shared with the Illinois Department of Public Health, the U.S. Centers for Disease Control and Prevention and GISAID, a global initiative that provides access to genomic data of influenza viruses and COVID-19, Rossi said.

Rossi said his goal in sharing the latest sequencing information is simply to keep the public aware of the spreading variants.

Coronavirus resources

Click here for the latest CDC novel coronavirus resources and links.
Track the COVID-19 globally using this map tracker here.

You can view the latest Illinois COVID-19 numbers here.

For mobile testing site locations, click here.
You can catch up on the latest 25 News coronavirus coverage here.

Sign up here for the latest local, state and national news, and weather updates.

The post Reditus Laboratories detects Indian COVID-19 variant in sample from Bloomington-Normal appeared first on WEEK.


Please enter your comment!
Please enter your name here